Field Market Access Manager, DACH at Cytokinetics

Munich, Bavaria, Germany

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, CardiovascularIndustries

Requirements

Strong stakeholder engagement skills
Deep understanding of regional healthcare dynamics in DACH (Germany, Austria, Switzerland)
Ability to operate independently while collaborating proactively across functions
Knowledge of regional and local reimbursement regulations, pricing, and health policy in cardiology

Responsibilities

Support commercial Key Account Managers with face-to-face HCP education on regional and local reimbursement regulations to address funding questions for high-value specialty care medicines in cardiology
Build and maintain strong relationships with regional payers, sick funds, SHI physicians’ associations, hospital controllers, retail pharmacists, and other healthcare decision-makers
Engage with drug evaluation committees and payer organizations to facilitate patient access and reduce funding barriers
Represent the company in compliant interactions, offering value-added solutions to support access and reimbursement
Visit HCPs together with commercial Key Account Managers on a regular basis
Collaborate closely with Sales, Marketing, Medical, and other internal teams to align on access priorities and ensure coordinated execution
Contribute to cross-functional projects that enhance regional access and create win-win solutions with stakeholders
Provide tools, training, and insights to support field teams in overcoming market access barriers and pricing concerns of HCPs
Monitor and analyze regional healthcare developments, policy changes, and reimbursement trends
Collect and interpret local data to inform strategic planning and tactical execution
Share insights with internal teams to optimize market access approaches and anticipate challenges
Develop and deliver training presentations for sales teams and external stakeholders on relevant health policy, pricing, and reimbursement topics, tailored to specialty cardiology issues
Create and adapt materials that communicate the value of innovative specialty care products in a way that resonates with regional stakeholders
Present complex market access topics in a clear, audience-appropriate format at internal and external events
Plan, manage, and monitor regional projects, including contracts and agreements with payers, in coordination with the DACH Management Team
Organize and lead access-related events such as expert meetings, roundtables, and commercial meetings in both hospital and outpatient settings
Use both digital and analogue channels to engage with stakeholders and support collaboration
Implement regional pricing and reimbursement tactics
Engage with local payers and healthcare stakeholders
Address access barriers at hospital and office-based account level in cardiology care
Contribute to regional insights and data analysis
Provide tactical solutions to support successful reimbursement outcomes
Provide strategic input to align local execution with broader commercial objectives

Skills

Market Access

Reimbursement Strategy

Payer Engagement

Stakeholder Management

Healthcare Regulations

Pricing Tactics

Data Analysis

HCP Education

Regional Healthcare Dynamics

Key Account Management

Cytokinetics

Develops drugs for muscle function disorders

About Cytokinetics

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.

South San Francisco, CaliforniaHeadquarters

1998Year Founded

$58.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Risks

Increased competition could impact market share and profitability.

Potential delays in clinical trials could hinder drug commercialization.

Dependence on strategic partnerships may expose Cytokinetics to risks if challenges arise.

Differentiation

Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.

The company has a robust pipeline including omecamtiv mecarbil and aficamten.

Cytokinetics engages in strategic partnerships, like with Sanofi, to expand market reach.

Upsides

Recent investments indicate strong interest in muscle activators and inhibitors.

Strategic partnerships, like with Sanofi, expand market reach and potential revenue.

Significant funding from Royalty Pharma supports commercial launch and R&D advancements.

Land your dream remote job 3x faster with AI

Try Jobo Free